Y-mAbs Therapeutics Inc. (YMAB)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
2 |
$76,904 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
12 Dec 2023 |
WEDELL-WEDELLSBORG JOHAN |
Director |
11 Dec 2023 |
6,455 |
6.85 |
44,232 |
11 Dec 2023 |
WEDELL-WEDELLSBORG JOHAN |
Director |
11 Dec 2023 |
102,863 |
7.01 |
720,843 |
11 Dec 2023 |
WEDELL-WEDELLSBORG JOHAN |
Director |
08 Dec 2023 |
18,503 |
6.99 |
129,379 |
11 Dec 2023 |
WEDELL-WEDELLSBORG JOHAN |
Director |
07 Dec 2023 |
6,183 |
6.50 |
40,190 |
01 Dec 2023 |
WEDELL-WEDELLSBORG JOHAN |
Director |
29 Nov 2023 |
51,837 |
5.97 |
309,477 |
29 Nov 2023 |
WEDELL-WEDELLSBORG JOHAN |
Director |
28 Nov 2023 |
30,671 |
5.81 |
178,275 |
29 Nov 2023 |
WEDELL-WEDELLSBORG JOHAN |
Director |
27 Nov 2023 |
62,516 |
5.49 |
343,019 |
17 May 2023 |
WG BIOTECH APS |
Director |
15 May 2023 |
101,740 |
9.65 |
981,404 |
16 Nov 2022 |
RAJAH VIGNESH |
SVP & CMO |
15 Nov 2022 |
1,195 |
4.92 |
5,884 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock